Position
Composition Wealth, LLC in Sangamo Therapeutics, Inc
Back to the book · All holders of SGMOQ
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$7.17K$0.42 → $0.25
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 41.4K | $17.4K | — | — | — | 0.0% |
| Q1 2026 | 41.4K | $10.2K | $0.25 | −$7.17K | −$0 | 0.0% |